BIOMAT Database Logo BIOMAT Database Logo

Glucose, insulin, and somatostatin infusion for the determination of insulin sensitivity in vivo. 1978

Y Harano, and H Hidaka, and K Takatsuki, and S Ohgaku, and M Haneda, and S Motoi, and K Kawagoe, and Y Shigeta, and H Abe

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D003927 Diet, Diabetic A course of food intake prescribed for patients, that limits the amount of foods with a high GLYCEMIC INDEX. Diabetic Diet,Diabetic Diets,Diets, Diabetic
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone

Related Publications

Y Harano, and H Hidaka, and K Takatsuki, and S Ohgaku, and M Haneda, and S Motoi, and K Kawagoe, and Y Shigeta, and H Abe
Glucose, insulin and somatostatin infusion for the determination of insulin resistance in liver cirrhosis.
October 1979, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Y Harano, and H Hidaka, and K Takatsuki, and S Ohgaku, and M Haneda, and S Motoi, and K Kawagoe, and Y Shigeta, and H Abe
The effect of somatostatin on insulin and glucose levels during insulin infusion in anesthetized dogs.
November 1990, Pancreas,
Y Harano, and H Hidaka, and K Takatsuki, and S Ohgaku, and M Haneda, and S Motoi, and K Kawagoe, and Y Shigeta, and H Abe
[Measurement of insulin sensitivity using the somatostatin-insulin-glucose test. Importance of the determination of plasma free fatty acids and insulin clearance].
November 1983, Presse medicale (Paris, France : 1983),
Y Harano, and H Hidaka, and K Takatsuki, and S Ohgaku, and M Haneda, and S Motoi, and K Kawagoe, and Y Shigeta, and H Abe
Effects of somatostatin added to insulin in a glucose-controlled insulin infusion system.
August 1981, Diabetologia,
Y Harano, and H Hidaka, and K Takatsuki, and S Ohgaku, and M Haneda, and S Motoi, and K Kawagoe, and Y Shigeta, and H Abe
Glucose infusion potentiates the acute insulin response to nonglucose stimuli during the infusion of somatostatin.
November 1979, Endocrinology,
Y Harano, and H Hidaka, and K Takatsuki, and S Ohgaku, and M Haneda, and S Motoi, and K Kawagoe, and Y Shigeta, and H Abe
Perioperative insulin and glucose infusion maintains normal insulin sensitivity after surgery.
July 1998, The American journal of physiology,
Y Harano, and H Hidaka, and K Takatsuki, and S Ohgaku, and M Haneda, and S Motoi, and K Kawagoe, and Y Shigeta, and H Abe
In vivo techniques for assessment of insulin sensitivity and glucose metabolism.
March 2024, The Journal of endocrinology,
Y Harano, and H Hidaka, and K Takatsuki, and S Ohgaku, and M Haneda, and S Motoi, and K Kawagoe, and Y Shigeta, and H Abe
Effects of norepinephrine infusion on in vivo insulin sensitivity and responsiveness.
August 1990, The American journal of physiology,
Y Harano, and H Hidaka, and K Takatsuki, and S Ohgaku, and M Haneda, and S Motoi, and K Kawagoe, and Y Shigeta, and H Abe
Effects of the somatostatin analog, octreotide, on glucose metabolism and insulin sensitivity in insulin-dependent diabetes mellitus.
February 1996, Metabolism: clinical and experimental,
Y Harano, and H Hidaka, and K Takatsuki, and S Ohgaku, and M Haneda, and S Motoi, and K Kawagoe, and Y Shigeta, and H Abe
Determination of immunoreactive somatostatin in rat plasma and responses to arginine, glucose and glucagon infusion.
November 1979, Diabetologia,
Copied contents to your clipboard!